HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SKB BIO

538.000

+5.0000.94%

Volume:561.82K

Turnover:301.87M

Market Cap:128.58B

PE:-278.33

High:545.000

Open:541.500

Low:527.500

Close:533.000

52wk High:581.000

52wk Low:339.600

Shares:239.00M

HK Float Shares:177.00M

Volume Ratio:0.80

T/O Rate:0.32%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.933

ROE:2.92%

ROA:0.03%

PB:20.65

PE(LYR):-278.33

PS:52.84

Loading ...

Overview Company News Filings

Merck Rises After Partner Kelun-biotech Reports Positive Keytruda Lung Cancer Study

SKB BIO Secures HK$2.7 Billion Placement to Fund R&D, Total Post-IPO Fundraising Approaches HK$7 Billion

China NMPA Clears Kelun-biotech, Harbour Biomed Asthma IND for Skb575/hbm7575

Hbm Holdings - Hbm7575 Co-developed by Harbour Biomed and Kelun-biotech

THOMSON REUTERS

Kelun-biotech and Harbour Biomed Announce Nmpa Approval of Ind Application for Skb575/hbm7575 for the Treatment of Asthma

THOMSON REUTERS

Kelun-Biotech's Lung Cancer Drug Trial Meets Primary Endpoint

MT Newswires Live

Innovative Drug Stocks Surge Following Inclusion in National Essential Medicines List, Accelerating Grassroots Access

Movement Alert｜Kelun-Biotech Rises 10.8% in Regular Trading, Core TROP2 ADC Achieves Phase III Primary Endpoint in PD-L1 Negative NSCLC

Sichuan Kelun-biotech Biopharma Says Primary Endpoint Met for Phase 3 Study of Lung Cancer Treatment

SKB BIO's Pivotal Drug Candidate Achieves Primary Endpoint in Phase 3 Lung Cancer Trial

Kelun-Biotech’s sac-TMT + Keytruda Clears Phase 3 PFS Hurdle in First-Line PD-L1-Negative NSCLC

Bulletin Express

Kelun-biotech Says Phase 3 Sac-tmt Plus Keytruda Meets PFS Endpoint in First-line Pd-l1-negative NSCLC

Sichuan Kelun-biotech Biopharmaceutical - Primary Endpoint Met for Phase 3 Study of Trop2 ADC Sacituzumab Tirumotecan with Pembrolizumab

THOMSON REUTERS

GLMS SEC: Significant Room for Improvement in First-Line Advanced Lung Cancer Treatment; Focus on SKB BIO's Global R&D Progress for sac-TMT

Movement Alert｜Kelun-Biotech Declines 3.17% in Regular Trading, Post-Placement Technical Pullback Continues

Movement Alert｜Kelun-Biotech Biopharmaceutical Intraday Decline 3.1%, Technical Pullback Following Completion of HK$2.72 Billion Share Placement

SKB BIO Releases Updated Articles of Association Following Hong Kong H-Share Listing

Bulletin Express

SKB BIO Completes HK$2.72 Billion H-Share Placement; Core Shareholder’s Stake Eases to 62.53%

Bulletin Express

SKB BIO Completes HKD 2.75 Billion H-Share Placement, Expanding Issued Capital by 3.41%

Bulletin Express

Kelun-biotech Files HKEX Next-day Disclosure Return, Share Capital Rises on 5,838,000 New H Shares Placing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/06990/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO","latestPrice":538,"timestamp":1787299688008,"preClose":533,"halted":0,"volume":561824,"delay":0,"changeRate":0.009380863039399626,"floatShares":177000000,"shares":239000000,"eps":-1.9329315267247398,"marketStatus":"Not Yet Opened","change":5,"latestTime":"08-21 16:08:08","open":541.5,"high":545,"low":527.5,"amount":301866735,"amplitude":0.032833,"askPrice":538,"askSize":1100,"bidPrice":537.5,"bidSize":1100,"shortable":3,"etf":0,"ttmEps":0.7562445996973522,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":533,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.7972975352660581,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":177000000,"roa":"0.03%","roe":"2.92%","lyrEps":-1.932932,"volumeRatio":0.7972975352660581,"shares":239000000,"dividePrice":0,"high":545,"amplitude":0.032833,"preClose":533,"low":527.5,"week52Low":339.6,"pbRate":"20.65","psRate":"52.84","week52High":581,"institutionHeld":0,"latestPrice":538,"eps":-1.9329315267247398,"divideRate":0,"volume":561824,"delay":0,"ttmEps":0.7562445996973522,"open":541.5,"prevYearClose":392.2,"prevWeekClose":538,"prevMonthClose":483.8,"prevQuarterClose":436.2,"fiveDayClose":520.5,"twentyDayClose":514,"sixtyDayClose":474},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2026-08-17","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786930200000,"name":null,"time":"","dateTimestamp":1786896000000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"06990","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post-Mkt","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"Post-Mkt","dateTimestamp":1723996800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":21,"updateTime":1786636800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2026-08-21","current":711.427569,"percent":0.998696,"low":-351.800852,"twenty":-236.676246,"median":-135.748112,"eighty":-53.902639,"high":737.230287,"avg":-137.360118,"sd":103.774207,"marketCap":128594895322},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-07","current":-120.930715,"twenty":-203.710245,"median":-131.985022,"eighty":-48.610423,"marketCap":95373061321},{"date":"2025-11-14","current":-137.099974,"twenty":-201.138492,"median":-131.729362,"eighty":-48.622244,"marketCap":108431475585},{"date":"2025-11-21","current":-125.836792,"twenty":-194.360264,"median":-130.233026,"eighty":-48.651606,"marketCap":99477134375},{"date":"2025-11-28","current":-134.139839,"twenty":-194.090443,"median":-131.64896,"eighty":-48.675637,"marketCap":106426076251},{"date":"2025-12-05","current":-134.965867,"twenty":-192.863217,"median":-131.473703,"eighty":-48.751223,"marketCap":107265545740},{"date":"2025-12-12","current":-128.449432,"twenty":-188.527876,"median":-130.526276,"eighty":-48.814858,"marketCap":102275366003},{"date":"2025-12-19","current":-122.479247,"twenty":-187.446049,"median":-129.499037,"eighty":-48.911385,"marketCap":97751558204},{"date":"2025-12-24","current":-122.098928,"twenty":-187.290368,"median":-128.758533,"eighty":-48.913338,"marketCap":97751558204},{"date":"2026-01-02","current":-116.223952,"twenty":-179.729041,"median":-128.478737,"eighty":-49.104524,"marketCap":93414299181},{"date":"2026-01-09","current":-137.872108,"twenty":-173.799059,"median":-128.508043,"eighty":-49.251224,"marketCap":111089795631},{"date":"2026-01-16","current":-136.67551,"twenty":-173.152374,"median":-129.252083,"eighty":-49.296233,"marketCap":110483512112},{"date":"2026-01-23","current":-124.044288,"twenty":-172.874196,"median":-128.511935,"eighty":-49.590244,"marketCap":100176692282},{"date":"2026-01-30","current":-119.398299,"twenty":-172.654145,"median":-128.43808,"eighty":-50.08289,"marketCap":96865451522},{"date":"2026-02-06","current":-121.3325,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"marketCap":98684302080},{"date":"2026-02-13","current":-119.328264,"twenty":-171.604872,"median":-127.229577,"eighty":-50.349599,"marketCap":97611646623},{"date":"2026-02-20","current":-118.929435,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"marketCap":97145274685},{"date":"2026-02-27","current":-109.393801,"twenty":-170.608939,"median":-126.362178,"eighty":-50.420375,"marketCap":90336244390},{"date":"2026-03-06","current":-109.941252,"twenty":-169.952459,"median":-125.237252,"eighty":-50.5225,"marketCap":90056421227},{"date":"2026-03-13","current":-111.874188,"twenty":-169.826622,"median":-125.028422,"eighty":-50.583009,"marketCap":92061820561},{"date":"2026-03-20","current":-118.784792,"twenty":-169.647858,"median":-124.510593,"eighty":-50.752344,"marketCap":97378460654},{"date":"2026-03-27","current":-246.717525,"twenty":-170.608939,"median":-124.791344,"eighty":-50.880899,"marketCap":106705913600},{"date":"2026-04-02","current":-270.1664,"twenty":-172.638036,"median":-125.053164,"eighty":-50.929189,"marketCap":117409151000},{"date":"2026-04-10","current":-262.507699,"twenty":-173.162671,"median":-125.237252,"eighty":-50.974222,"marketCap":114960698000},{"date":"2026-04-17","current":-276.768173,"twenty":-188.270393,"median":-126.362178,"eighty":-51.053793,"marketCap":121256720000},{"date":"2026-04-24","current":-263.25072,"twenty":-199.457552,"median":-126.777731,"eighty":-51.109685,"marketCap":115341038016},{"date":"2026-04-30","current":-249.758244,"twenty":-207.783795,"median":-127.598017,"eighty":-51.131881,"marketCap":109457493848},{"date":"2026-05-08","current":-237.123047,"twenty":-214.424086,"median":-128.140667,"eighty":-51.206724,"marketCap":104280765336},{"date":"2026-05-15","current":-230.895214,"twenty":-220.549694,"median":-128.478737,"eighty":-51.422215,"marketCap":101808994065},{"date":"2026-05-22","current":-251.35436,"twenty":-225.355554,"median":-129.00513,"eighty":-51.539533,"marketCap":110576786499},{"date":"2026-05-29","current":-244.039033,"twenty":-227.151092,"median":-129.499037,"eighty":-51.775379,"marketCap":107731917678},{"date":"2026-06-05","current":-207.501784,"twenty":-227.151092,"median":-130.526276,"eighty":-51.91711,"marketCap":91735360204},{"date":"2026-06-12","current":-219.148588,"twenty":-226.740676,"median":-131.473703,"eighty":-52.267792,"marketCap":96818814328},{"date":"2026-06-18","current":-218.939992,"twenty":-226.404961,"median":-131.824218,"eighty":-52.561632,"marketCap":96958725910},{"date":"2026-06-26","current":-221.178526,"twenty":-225.594566,"median":-132.326202,"eighty":-52.73121,"marketCap":97471735042},{"date":"2026-07-03","current":-263.841103,"twenty":-227.197711,"median":-132.771691,"eighty":-52.93717,"marketCap":116359798531},{"date":"2026-07-10","current":-273.42961,"twenty":-228.864297,"median":-133.50718,"eighty":-53.148078,"marketCap":120440552988},{"date":"2026-07-17","current":-263.005613,"twenty":-229.666754,"median":-134.182751,"eighty":-53.480935,"marketCap":116261258521},{"date":"2026-07-24","current":-277.867014,"twenty":-230.754675,"median":-134.677954,"eighty":-54.022455,"marketCap":122858320066},{"date":"2026-07-31","current":-261.04507,"twenty":-231.704791,"median":-134.965867,"eighty":-54.274788,"marketCap":115639796202},{"date":"2026-08-07","current":-290.535115,"twenty":-235.013451,"median":-135.70577,"eighty":-54.298503,"marketCap":128953431275},{"date":"2026-08-14","current":-279.9487,"twenty":-236.676246,"median":-136.101797,"eighty":-54.329175,"marketCap":124411975864},{"date":"2026-08-21","current":729.337059,"twenty":-236.676246,"median":-135.748112,"eighty":-53.902639,"marketCap":128594895322}],"updateTime":1787514423076},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651970463","title":"Merck Rises After Partner Kelun-biotech Reports Positive Keytruda Lung Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2651970463","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651970463?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:38","pubTimestamp":1784119100,"startTime":"0","endTime":"0","summary":"BUZZ-Merck rises after partner Kelun-Biotech reports positive Keytruda lung cancer studyUpdates** Shares of drugmaker MerckMRK.Ngains 2.59% to $123.91 premarket** Partner Kelun-Biotech on Tuesday said a late-stage study of its experimental cancer drug sac-TMT in combination with Merck's Keytruda met the main goal in first-line advanced lung cancer patients whose tumors lacked PD-L1 expression** Kelun says the combination helped patients live longer without their disease worsening versus Keytruda plus chemotherapy and showed a positive trend toward overall survival** The study is the first late-stage trial of an antibody-drug conjugate and immunotherapy combination to meet its main goal in this first-line lung cancer setting, according to Kelun**The data support the potential for sac-TMT plus Keytruda to challenge current standard-of-care regimens across a broader first-line lung cancer population - Leerink Partners analyst Akash Tewari** Separately, MRKon Wednesday saidits cancer drug ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nL4N43H13X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU0432979614.USD","LU0130517989.USD","BK1161","LU1066051225.USD","LU2491049909.HKD","LU1989771016.USD","LU1974910355.USD","LU1037948897.HKD","LU2461242641.AUD","SG9999014559.SGD","06990","SGXZ57979304.SGD","IE00BJT1NW94.SGD","LU1430594728.SGD","LU0689626769.HKD","GDOC","LU2491050154.USD","LU0965509101.SGD","LU1037948541.HKD","LU0098860793.USD","LU1093756325.SGD","VHT","SG9999014542.SGD","LU0196878994.USD","LU2357627491.SGD","LU0203345920.USD","LU0058720904.USD","LU0861579265.USD","PPH","LU0106261372.USD","LU0006306889.USD","LU1934455194.USD","LU0124676726.USD","LU1989772923.USD","IE00BSNM7G36.USD","LU0965509010.AUD","LU0289739699.SGD","IE00BBT3K403.USD","LU0234572021.USD","IE00BN8TJ469.HKD","LU0130102774.USD","HRTS","BMED","IE00BFTCPJ56.SGD","IE00B1BXHZ80.USD","LU1116320901.HKD","LU2361044865.SGD","SG9999013999.USD","LU1069347547.HKD","LU1983299246.USD","LU2023250843.SGD","LU0208291251.USD","LU1585245621.USD","LU0320765489.SGD","BK4585","LU2468319806.SGD","SG9999002232.USD","LU0203347892.USD","SG9999001176.SGD","SG9999001440.SGD","SG9999014575.USD","LU1057294990.SGD","LU2361045086.USD","LU0320765646.SGD","LU1291159041.SGD","LU0070302665.USD","LU1929549753.HKD","LU2023250504.SGD","LU0868494617.USD","LU0648001328.SGD","IE0002141913.USD","BK4534","MRK","BK4550","LU0965508806.USD","SG9999015341.SGD","FTXH","SG9999001176.USD","LU1162221912.USD","LU1571399168.USD","LU1035773651.USD","SG9999002224.SGD","LU0238689110.USD","IYH","LU1023059063.AUD","LU0122379950.USD","LU0265550359.USD","LU0477156953.USD","LU0980610538.SGD","XLV","LU2433249047.HKD","IXJ","LU1093756168.USD","IE00BLSP4239.USD","LU1941712264.USD","LU0265550946.USD","LU2125909247.SGD","SG9999015358.SGD","BK4588","LU1699723380.USD","LU2361044949.HKD","BK4516","LU1201861249.SGD","LU2491050071.SGD","BK4559","LU2360032135.SGD","LU1066051811.HKD","BK4007","FHLC","LU0211331839.USD","SG9999014567.USD","IHE","LU1066053197.SGD","LU1941712348.USD","LU0868494708.USD","IE00B4R5TH58.HKD","LU1934455863.HKD","LU2125154778.USD","BK4533","LU1923622614.USD","PAWZ","LU1116320737.USD","LU1989772840.SGD","LU0266013472.USD","LU2106854487.HKD","LU1061106388.HKD","IE000M9KFDE8.USD","LU2112291526.USD","LU0859254822.USD","LU0965509283.SGD","IE00BLSP4452.SGD","IE00B2B36J28.USD","LU2125154935.USD","LU0985320562.USD","IE00BJJMRZ35.SGD","LU0942090050.USD","RXL","LU1066051498.USD","LU1917777945.USD","IE0009355771.USD","LU2125909593.SGD","JDOC","LU1934455277.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191169154","title":"SKB BIO Secures HK$2.7 Billion Placement to Fund R&D, Total Post-IPO Fundraising Approaches HK$7 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1191169154","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191169154?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:01","pubTimestamp":1784113298,"startTime":"0","endTime":"0","summary":"On July 10, SKB BIO (06990.HK) announced the successful completion of a new H-share placement, raising net proceeds of approximately HK$2.723 billion.This innovative biotech company, which listed...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","IPOS","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451920","title":"China NMPA Clears Kelun-biotech, Harbour Biomed Asthma IND for Skb575/hbm7575","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451920","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651451920?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:02","pubTimestamp":1784109748,"startTime":"0","endTime":"0","summary":"China NMPA clears Kelun-Biotech, Harbour BioMed asthma IND for SKB575/HBM7575China’s NMPA cleared an IND for SKB575/HBM7575, a long-acting bispecific antibody for asthma.The drug is co-developed by Ke","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL9mBrfs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2148510915.USD","LU1064130708.USD","LU1934453819.USD","06990","02142","BK1574","002422","LU1979443071.USD","BK1583","BK0060","BK1161","LU0196878994.USD","BK0239","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451667","title":"Hbm Holdings - Hbm7575 Co-developed by Harbour Biomed and Kelun-biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651451667?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:00","pubTimestamp":1784109651,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0F9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","LU0196878994.USD","BK1574","02142","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451612","title":"Kelun-biotech and Harbour Biomed Announce Nmpa Approval of Ind Application for Skb575/hbm7575 for the Treatment of Asthma","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451612","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651451612?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:00","pubTimestamp":1784109604,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUABBJB5T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","BK1161","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651436131","title":"Kelun-Biotech's Lung Cancer Drug Trial Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2651436131","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651436131?lang=en_us&edition=fundamental","pubTime":"2026-07-15 11:46","pubTimestamp":1784087219,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical's  phase 3 study of sacituzumab tirumotecan  combined with Merck's Keytruda met the primary endpoint in first-line treatment of PD-L1-negative advanced non-squamous non-small cell lung cancer, according to a Wednesday Hong Kong bourse filing.The study showed the combination significantly improved progression-free survival compared with pembrolizumab plus chemotherapy.An interim analysis also indicated a positive trend in overall survival, while no new safety signals were identified.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06990","BK4588","LU0196878994.USD","BK1161","BK4581","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101227446","title":"Innovative Drug Stocks Surge Following Inclusion in National Essential Medicines List, Accelerating Grassroots Access","url":"https://stock-news.laohu8.com/highlight/detail?id=1101227446","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101227446?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:56","pubTimestamp":1784084190,"startTime":"0","endTime":"0","summary":"Shares of innovative drug companies are leading gains in the Hong Kong market.SKB BIO (06990) rose 10.5% to HK$550.5, while INNOVENT BIO (01801) gained 8.38% to HK$97.6. AKESO (09926) advanced 7.88%...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","01801","01530","BK1593","HK0000165453.HKD","LU1961090484.USD","LU2488822045.USD","KCAI","BK1589","LU0455707207.USD","LU1794554557.SGD","VXUS","LU2097828714.EUR","LU1720050803.USD","LU0417516571.SGD","LU0348735423.USD","MEDX","LU0634319403.HKD","LU0348767384.USD","LU0196878994.USD","09926","LU2097828631.EUR","LU0348783233.USD","LU2097828557.USD","LU2242644610.SGD","LU0417516902.SGD","LU0348827113.USD","LU2778985437.USD","BK1574","LU1969619763.USD","LU0417516738.SGD","LU2328871848.SGD","LU0502904849.HKD","159992","IE00BPRC5H50.USD","LU0540923850.HKD","LU0348825331.USD","KURE","IE00B5MMRT66.SGD","06990","LU0348766576.USD","LU2399975544.HKD","LU0348784397.USD","BK4585","06978","LU2476274720.SGD","LU0561508036.HKD","LU2476274308.USD","IBBQ","IE00B543WZ88.USD","LU2097828474.EUR","LU2097828805.USD","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102600985","title":"Movement Alert｜Kelun-Biotech Rises 10.8% in Regular Trading, Core TROP2 ADC Achieves Phase III Primary Endpoint in PD-L1 Negative NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1102600985","media":"Market Focus","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102600985?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:39","pubTimestamp":1784083181,"startTime":"0","endTime":"0","summary":"On July 15, Kelun-Biotech (06990.HK) rose 10.8% in regular trading to HK$552.0, with turnover of HK$465 million.The rally was driven by the company announcing that its core product sacituzumab...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651480077","title":"Sichuan Kelun-biotech Biopharma Says Primary Endpoint Met for Phase 3 Study of Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2651480077","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651480077?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:20","pubTimestamp":1784078400,"startTime":"0","endTime":"0","summary":"BRIEF-Sichuan Kelun-Biotech Biopharma Says Primary Endpoint Met For Phase 3 Study Of Lung Cancer TreatmentJuly 15 (Reuters)-Sichuan Kelun-Biotech Biopharmaceutical Co Ltd6990.HK:PRIMARY ENDPOINT MET F","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43G19N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197384924","title":"SKB BIO's Pivotal Drug Candidate Achieves Primary Endpoint in Phase 3 Lung Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1197384924","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197384924?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:44","pubTimestamp":1784072678,"startTime":"0","endTime":"0","summary":"SKB BIO (ASX: 06990) has announced that its Phase 3 clinical trial for the combination therapy of its core TROP2-targeting antibody-drug conjugate (ADC), sac-TMT (also known as SKB264/MK-2870), with...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","LU0196878994.USD","BK4023","PD","LU1169589451.USD","BK1161","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119756156","title":"Kelun-Biotech’s sac-TMT + Keytruda Clears Phase 3 PFS Hurdle in First-Line PD-L1-Negative NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1119756156","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119756156?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:40","pubTimestamp":1784072440,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Kelun-Biotech) announced that an Independent Data Monitoring Committee has confirmed the Phase 3 OptiTROP-Lung06 trial met its primary endpoint. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651482461","title":"Kelun-biotech Says Phase 3 Sac-tmt Plus Keytruda Meets PFS Endpoint in First-line Pd-l1-negative NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2651482461","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651482461?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:24","pubTimestamp":1784071455,"startTime":"0","endTime":"0","summary":"Kelun-Biotech says Phase 3 sac-TMT plus Keytruda meets PFS endpoint in first-line PD-L1-negative NSCLCSichuan Kelun-Biotech reported its Phase 3 OptiTROP-Lung06 study met the primary endpoint of progr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDLbLHStv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651431482","title":"Sichuan Kelun-biotech Biopharmaceutical - Primary Endpoint Met for Phase 3 Study of Trop2 ADC Sacituzumab Tirumotecan with Pembrolizumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2651431482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651431482?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:23","pubTimestamp":1784071412,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G19N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0196878994.USD","06990","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143660492","title":"GLMS SEC: Significant Room for Improvement in First-Line Advanced Lung Cancer Treatment; Focus on SKB BIO's Global R&D Progress for sac-TMT","url":"https://stock-news.laohu8.com/highlight/detail?id=1143660492","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143660492?lang=en_us&edition=fundamental","pubTime":"2026-07-14 15:30","pubTimestamp":1784014245,"startTime":"0","endTime":"0","summary":"A recent report from GLMS SEC highlights that substantial opportunities for advancement remain in the first-line treatment of advanced lung cancer. This is due to limited survival benefits for many...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1119993845.HKD","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","LU0877626530.USD","LU0890818403.SGD","IE0008368742.USD","LU0868486357.SGD","BK1564","LU0196878994.USD","IE00BZ08YT58.USD","601456","LU0640798160.USD","LU0593848301.USD","IE00BMCWC346.EUR","LU0205439572.USD","06990","LU2048586759.USD","BK1607","LU0862451753.SGD","LU2476274308.USD","BK1161","161027","IE00BYV24P56.USD","LU1115378108.SGD","IE0008369823.USD","IE00B031HY20.USD","IE00BZ08YR35.GBP","BK1214","IE0034224299.USD","LU2778985437.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD","BK0276","LU1655091616.SGD","01456","BK1147","BK1557","LU0431992006.USD","IE00B29SXG58.USD","LU2279701549.SGD","06690"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152270577","title":"Movement Alert｜Kelun-Biotech Declines 3.17% in Regular Trading, Post-Placement Technical Pullback Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=1152270577","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152270577?lang=en_us&edition=fundamental","pubTime":"2026-07-14 10:05","pubTimestamp":1783994702,"startTime":"0","endTime":"0","summary":"On July 14, Kelun-Biotech fell 3.17% in regular trading, trading at HK$500.5/share, with turnover of HK$135 million.On the news front, the company completed a placement of 5.838 million new H shares...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128287343","title":"Movement Alert｜Kelun-Biotech Biopharmaceutical Intraday Decline 3.1%, Technical Pullback Following Completion of HK$2.72 Billion Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=1128287343","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128287343?lang=en_us&edition=fundamental","pubTime":"2026-07-13 09:47","pubTimestamp":1783907233,"startTime":"0","endTime":"0","summary":"On July 13, Kelun-Biotech Biopharmaceutical fell 3.1% in regular trading, trading at HK$489.2/share, with turnover of HK$208 million. The decline represents a technical correction following a sharp...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109702331","title":"SKB BIO Releases Updated Articles of Association Following Hong Kong H-Share Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1109702331","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109702331?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:22","pubTimestamp":1783675372,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has published its revised Articles of Association, now effective after the company’s 11 July 2023 debut on the Hong Kong Stock Exchange...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173568073","title":"SKB BIO Completes HK$2.72 Billion H-Share Placement; Core Shareholder’s Stake Eases to 62.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173568073","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173568073?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:22","pubTimestamp":1783675346,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has closed its previously announced H-share placement, issuing 5.84 million new shares at HK$470.20 each. All terms under the placing...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180080507","title":"SKB BIO Completes HKD 2.75 Billion H-Share Placement, Expanding Issued Capital by 3.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=1180080507","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180080507?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:22","pubTimestamp":1783675345,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) confirmed the completion of a private placing of 5.84 million new H shares on 10 July 2026. The shares were issued at HKD 470.20 each,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650540186","title":"Kelun-biotech Files HKEX Next-day Disclosure Return, Share Capital Rises on 5,838,000 New H Shares Placing","url":"https://stock-news.laohu8.com/highlight/detail?id=2650540186","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650540186?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:20","pubTimestamp":1783675234,"startTime":"0","endTime":"0","summary":"Kelun-Biotech files HKEX next-day disclosure return, share capital rises on 5,838,000 new H shares placingSichuan Kelun-Biotech filed a next day disclosure return on July 10, 2026 following completion","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDLbCgPLZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002422","BK0239","BK0060","LU2148510915.USD","LU1934453819.USD","BK1161","06990","LU0196878994.USD","LU1979443071.USD","LU1064131003.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}